PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:40 AM ET

Sponsor Check › Person

SB
No photo found yet (own website and image search run after this page is viewed)

Sol J Barer

Named as an officer, director or promoter on SEC Form D filings · NJ, NY, MD, Israel (as filed: L3), CA, PA, MA · Nov 5, 2010 → Apr 9, 2015

9deals (issuers)
$635.5Mreported sold
853investors
44Form D filings
2010–2015years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:22 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Sol J Barer is listed as a director on 44 SEC Form D filings by 9 issuers between Nov 2010 and Aug 2022. Largest by amount reported sold: AMICUS THERAPEUTICS, INC. (Princeton, NJ — biotechnology — 2010–2016; $199.9M reported sold to 29 investors), Avalo Therapeutics, Inc. (Rockville, MD — biotechnology — 2012–2014; $130.6M reported sold to 156 investors), Diffusion Pharmaceuticals Inc. (Charlottesville, VA — pharmaceuticals — 2014; $85.7M reported sold to 181 investors), Centrexion Therapeutics Corp (Boston, MA — biotechnology — 2013–2022; $69.6M reported sold to 124 investors), Edge Therapeutics, Inc. (Berkeley Heights, NJ — pharmaceuticals — 2012–2015; $56M reported sold to 104 investors) and 4 more (all listed below).

What this means A repeat sponsor — 9 separate companies raised money with this person listed as director, over about 12 years. Across those companies the filings report $635.5M sold in total.

Listed alongside Isaac Blech (19 shared filings), Craig Shore (13 shared filings), Asher Holzer (11 shared filings), Eyal Weinstein (11 shared filings), Ofir Paz (11 shared filings) and 104 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Sol. Each name links to their own page.

1 of the issuers belongs to the sponsor group Diffusion Pharmaceuticals (2 issuers, $3.15M reported sold, 2009–2020).

What this means A sponsor group is one team that sets up a new company for each deal. Diffusion Pharmaceuticals has 2 companies on file and $3.15M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 6 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.

What this means 8 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 44 public filings for Sol J Barer and found 16 differences, 2 worth asking the sponsor about: 5 court cases name Sol J Barer; 11 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Sol J Barer has not run yet — it is joining a line of 25,323 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

6 cases: 1 open, 3 judgment, 2 dismissed

Sinclair & Wilde, LTD. v. Barer Holding Co open
District Court, S.D. New York · No. 1:24-cv-08488 · Filed Nov 7, 2024 · Nature of suit: 320 Assault Libel & Slander · Cause: 28:1332lb Diversity-Libel, Assault, Slander
Role of Barer Holding Co: Defendant · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); surname only in the caption; court in the person's filing state (NY)
Zimmermann, Inc. v. Barer Engineering Company of America judgment
District Court, D. Vermont · No. 2:11-cv-00071 · Filed Mar 21, 2011 · Closed Jun 19, 2012 · Nature of suit: Contract: Other · Cause: 28:1332 Diversity-Breach of Contract
Role of Barer Engineering Company of America: Defendant · Outcome: Terminated 2012-06-19 — FJC Integrated Database disposition: Judgment on default; judgment for plaintiff Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); surname only in the caption; court in VT (not a filing state)
Zimmerman, Inc. v. Barer Engineering Co. of America dismissed
District Court, E.D. Michigan · No. 2:10-cv-10608 · Filed Feb 11, 2010 · Closed Jul 7, 2010 · Nature of suit: 190 Other contract actions
Role of Barer Engineering Co. of America: Defendant · Outcome: Terminated 2010-07-07 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); surname only in the caption; court in MI (not a filing state)
Knight Brothers v. Barer Engineering Company of America judgment
District Court, D. Utah · No. 2:10-cv-00108 · Filed Feb 10, 2010 · Closed Aug 29, 2012 · Nature of suit: 190 Contract: Other · Cause: 28:1441 Notice of Removal- Breach of Contract
Role of Barer Engineering Company of America: Defendant · Outcome: Terminated 2012-08-29 — FJC Integrated Database disposition: Judgment on motion before trial; judgment for plaintiff Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); surname only in the caption; court in UT (not a filing state)
Garvey Schubert Barer v. Nexantis Corporation dismissed
District Court, D. Oregon · No. 3:05-cv-01959 · Filed Dec 30, 2005 · Closed Apr 5, 2007 · Nature of suit: 190 Other contract actions
Role of Garvey Schubert Barer: Plaintiff · Outcome: Terminated 2007-04-05 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); different first name (schubert); court in OR (not a filing state)
Barer v. Dr.koop.com, Inc. judgment
District Court, W.D. Texas · No. 1:00-cv-00453 · Filed Jul 27, 2000 · Closed Nov 14, 2001 · Nature of suit: 850 Securities/Commodities · Cause: 15:77 Securities Fraud
Role of Barer: Plaintiff · Outcome: Terminated 2001-11-14 — FJC Integrated Database disposition: Other; judgment for plaintiff Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); surname only in the caption; court in TX (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Sol J Barer..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

Morrow Inc v. Garvey Schubert & Barer PC closed
United States Bankruptcy Court, D. Oregon · No. 02-03094 · Filed Mar 8, 2002 · Closed Mar 7, 2003
Role of Garvey Schubert & Barer PC: Defendant · Outcome: Case closed 2003-03-07 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); surname only in the caption; court in OR (not a filing state)
Stephen Barer Young and Mina Belle Young closed
United States Bankruptcy Court, W.D. Washington · No. 00-01110 · Filed Feb 3, 2000 · Closed Aug 21, 2000
Role of Stephen Barer Young and Mina Belle Young: Debtor · Outcome: Case closed 2000-08-21 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 15 federal dockets); different first name (stephen); court in WA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

16 differences found between the filings for Sol J Barer — 2 worth asking about (compared 44 filings on Oct 24, 2026)

Note · May 15, 1997 – Sep 14, 2011

5 bankruptcy cases name the subject or team members

Bankruptcy case: Robert C. Nowinski — filed Oct 25, 2002 · Bankruptcy case: Valenzano's Office Equipment & Supplies Inc. — filed Oct 14, 2005 · Bankruptcy case: Morrow Inc v. Garvey Schubert & Barer PC — filed Mar 8, 2002 · Bankruptcy case: AT&T Universal Card Services Corp. v. Valenzano — filed May 15, 1997 · Bankruptcy case: First USA Bank v. Valenzano — filed May 19, 1997

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, S.D. New York ↗Robert C. Nowinski — PartnerFacts page ↗Docket · United States Bankruptcy Court, D. New Jersey ↗Ken Valenzano — PartnerFacts page ↗
Sources
Worth asking · Jul 27, 2000 – Nov 7, 2024

5 court cases name Sol J Barer — 4 as defendant

By role: defendant in 4, plaintiff in 1. Newest: "Sinclair & Wilde, LTD. v. Barer Holding Co" (District Court, S.D. New York, Nov 7, 2024); "Zimmermann, Inc. v. Barer Engineering Company of America" (District Court, D. Vermont, Mar 21, 2011); "Zimmerman, Inc. v. Barer Engineering Co. of America" (District Court, E.D. Michigan, Feb 11, 2010). Some of these are name matches with a match estimate below 95% — check each docket.

What this means Several court cases name this subject. Some are routine business suits. Ask what each was about and how it ended.

Docket · Sinclair & Wilde, LTD. v. Barer Holding Co ↗Docket · Zimmermann, Inc. v. Barer Engineering Company of America ↗Docket · Zimmerman, Inc. v. Barer Engineering Co. of America ↗Docket · Knight Brothers v. Barer Engineering Company of America ↗
Sources
Worth asking · Mar 31, 2011 – May 23, 2017

11 Form Ds were filed more than 15 days after the first sale

Form D filed 61 days after the first sale — InspireMD, Inc. · Form D filed 130 days after the first sale — InspireMD, Inc. · Form D filed 148 days after the first sale — InspireMD, Inc. · Form D filed 148 days after the first sale — InspireMD, Inc. · Form D filed 148 days after the first sale — InspireMD, Inc. · and 6 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Oct 1, 2012 ↗InspireMD, Inc. — PartnerFacts page ↗Form D · Aug 26, 2011 ↗Form D · Aug 26, 2011 ↗
Sources
Note · Aug 31, 2011 – May 23, 2017

16 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Centrexion Therapeutics Corp (latest filing May 23, 2017) · No amendment in the last 12 months on an offering that may still be open — Centrexion Therapeutics Corp (latest filing Jun 21, 2016) · No amendment in the last 12 months on an offering that may still be open — Centrexion Therapeutics Corp (latest filing Apr 15, 2016) · No amendment in the last 12 months on an offering that may still be open — Centrexion Therapeutics Corp (latest filing Mar 14, 2016) · No amendment in the last 12 months on an offering that may still be open — Edge Therapeutics, Inc. (latest filing Apr 9, 2015) · and 11 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · May 23, 2017 ↗Centrexion Therapeutics Corp — PartnerFacts page ↗Form D · Jun 21, 2016 ↗Form D · Apr 15, 2016 ↗
Sources
Note · Jun 28, 2022 – Aug 11, 2022

Offering amount changed between filings — Centrexion Therapeutics Corp

The Jun 28, 2022 filing says $23,750,000 offered; the Aug 11, 2022 Form D/A says $29,140,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D/A (earlier) · Jun 28, 2022 ↗Form D/A (later) · Aug 11, 2022 ↗Centrexion Therapeutics Corp — PartnerFacts page ↗
Sources
Note · Jun 8, 2022 – Jun 28, 2022

Offering amount changed between filings — Centrexion Therapeutics Corp

The Jun 8, 2022 filing says $16,475,000 offered; the Jun 28, 2022 Form D/A says $23,750,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jun 8, 2022 ↗Form D/A (later) · Jun 28, 2022 ↗Centrexion Therapeutics Corp — PartnerFacts page ↗
Sources
Note · Nov 5, 2010 – Sep 15, 2011

Sol J Barer is written 2 different ways on the filings

listed as "Sol J Barer" on 19 filings (from Nov 5, 2010), and "Sol Barer" on 25 filings (from Sep 15, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Nov 5, 2010 ↗Form D · Sep 15, 2011 ↗Sol J Barer — PartnerFacts page ↗
Sources
Note · Aug 26, 2011 – Oct 1, 2012

Industry group changed between filings — InspireMD, Inc.

"Other" (Aug 26, 2011 to Apr 18, 2012); then "Biotechnology" (Oct 1, 2012 to Jun 16, 2016).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Aug 26, 2011 ↗Form D · Oct 1, 2012 ↗InspireMD, Inc. — PartnerFacts page ↗
Sources
Note · Oct 15, 2015 – Oct 19, 2017

Reported revenue range changed between filings — Aevi Genomic Medicine, Inc.

"Decline to Disclose" (Oct 15, 2015); then "No Revenues" (Oct 19, 2017).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Oct 15, 2015 ↗Form D · Oct 19, 2017 ↗Aevi Genomic Medicine, Inc. — PartnerFacts page ↗
Sources
Note · Nov 5, 2010 – Jul 19, 2016

Reported revenue range changed between filings — AMICUS THERAPEUTICS, INC.

"$25,000,001 - $100,000,000" (Nov 5, 2010); then "$5,000,001 - $25,000,000" (Jul 30, 2012); then "$1,000,001 - $5,000,000" (Dec 3, 2013); then "Decline to Disclose" (Jul 19, 2016).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Nov 5, 2010 ↗Form D · Jul 30, 2012 ↗Form D · Dec 3, 2013 ↗Form D · Jul 19, 2016 ↗
Sources
Note · Sep 17, 2012 – Nov 13, 2014

Reported revenue range changed between filings — Edge Therapeutics, Inc.

"Decline to Disclose" (Sep 17, 2012); then "No Revenues" (Mar 25, 2013); then "Decline to Disclose" (Nov 13, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Sep 17, 2012 ↗Form D · Mar 25, 2013 ↗Form D · Nov 13, 2014 ↗Edge Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 4, 2022

Same name, different state: "Sol Barer" (TX or VA) is a separate record

This page covers filings where the address state is NJ or NY or MD or L3 or CA or PA or MA. A separate record, "Sol Barer" with address state TX or VA, is listed on 2 filings — most recently by Zephyr AI, Inc. (Mar 13, 2024). The two records do not overlap in time: this page runs Nov 5, 2010 to Apr 9, 2015; the other has one filing dated Apr 4, 2022.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sol Barer (TX,VA) — PartnerFacts page ↗Form D · Mar 13, 2024 ↗Zephyr AI, Inc. — PartnerFacts page ↗Sol J Barer (NJ,NY,MD,L3,CA,PA,MA) — this page ↗
Sources
Note · Jan 5, 2017 – May 23, 2017

Address moved from Baltimore, MD to Boston, MA — Centrexion Therapeutics Corp

The people listed on the Jan 5, 2017 filing give Baltimore, MD; on the May 23, 2017 filing they give Boston, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jan 5, 2017 ↗Form D · May 23, 2017 ↗Centrexion Therapeutics Corp — PartnerFacts page ↗
Sources
Note · Jan 18, 2013 – Mar 28, 2016

Address moved from Tel Aviv, Israel (as filed: L3) to Boston, MA — InspireMD, Inc.

The people listed on the Jan 18, 2013 filing give Tel Aviv, Israel (as filed: L3); on the Mar 28, 2016 filing they give Boston, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jan 18, 2013 ↗Form D · Mar 28, 2016 ↗InspireMD, Inc. — PartnerFacts page ↗
Sources
Note · Mar 25, 2013 – Nov 13, 2014

Address moved from New Providence, NJ to Berkeley Heights, NJ — Edge Therapeutics, Inc.

The people listed on the Mar 25, 2013 filing give New Providence, NJ; on the Nov 13, 2014 filing they give Berkeley Heights, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Mar 25, 2013 ↗Form D · Nov 13, 2014 ↗Edge Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Nov 5, 2010 – Aug 11, 2022

Sol J Barer is listed with 7 different address states: NJ, NY, MD, L3, CA, PA, MA

NJ on 17 filings (Nov 5, 2010 to Jul 19, 2016); NY on 1 filing (Sep 15, 2011); MD on 10 filings (Apr 4, 2012 to Jan 5, 2017); Israel (as filed: L3) on 5 filings (Oct 1, 2012 to Jan 18, 2013); CA on 1 filing (May 22, 2014); PA on 2 filings (Oct 15, 2015 to Oct 19, 2017); MA on 8 filings (Mar 28, 2016 to Aug 11, 2022).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Nov 5, 2010 ↗Form D · Sep 15, 2011 ↗Form D · Apr 4, 2012 ↗Form D · Oct 1, 2012 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

16 of 40 offerings report sales commissions totalling $16,087,015; 5 report finder's fees totalling $7,174,599; 4 report proceeds to related persons totalling $2,546,348. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 11, 2022 D/A
Centrexion Therapeutics Corp
File 021-448502
$0$2,622,600 (est.)$0Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Jan 26, 2021 D
Centrexion Therapeutics Corp
File 021-387332
$0$945,000 (est.)$0Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Jan 2, 2018 D
Centrexion Therapeutics Corp
File 021-302145
$3,630,000 (est.)$0$0Maxim Group LLC BrokerCheck CRD 120708 ↗
Leerink Partners LLC BrokerCheck CRD 39011 ↗		EDGAR ↗
Oct 19, 2017 D
Aevi Genomic Medicine, Inc.
File 021-297065
$0$0$0None listed on this filingEDGAR ↗
May 23, 2017 D
Centrexion Therapeutics Corp
File 021-287301
$212,450$0$0Brookline Capital Markets no CRD number reported
via CIM Securities, LLC (CRD 120852 ↗)
EDGAR ↗
Jan 5, 2017 D
Centrexion Therapeutics Corp
File 021-277676
$1,325,183$0$0 (est.)N/A no CRD number reported
via Maxim Group LLC (CRD 120708 ↗)
EDGAR ↗
Jul 19, 2016 D
AMICUS THERAPEUTICS, INC.
File 021-267307
$5,000$5,000$0None listed on this filingEDGAR ↗
Jun 21, 2016 D
Centrexion Therapeutics Corp
File 021-265466
$669,810$0$0 (est.)N/A no CRD number reported
via Maxim Group LLC (CRD 120708 ↗)
EDGAR ↗
Jun 16, 2016 D
InspireMD, Inc.
File 021-265182
$0$0$0None listed on this filingEDGAR ↗
Apr 15, 2016 D
Centrexion Therapeutics Corp
File 021-261501
$318,300$0$0 (est.)N/A no CRD number reported
via Maxim Group LLC (CRD 120708 ↗)
EDGAR ↗
Mar 28, 2016 D
InspireMD, Inc.
File 021-260088
$48,760$0$0Dawson James Securities, Inc. BrokerCheck CRD 130645 ↗EDGAR ↗
Mar 14, 2016 D
Centrexion Therapeutics Corp
File 021-259218
$537,990$0$0 (est.)N/A no CRD number reported
via Maxim Group LLC (CRD 120708 ↗)
EDGAR ↗
Oct 15, 2015 D
Aevi Genomic Medicine, Inc.
File 021-249442
$0$0$0None listed on this filingEDGAR ↗
Apr 9, 2015 D
Edge Therapeutics, Inc.
File 021-237569
$0$3,301,999$0
A portion of the proceeds may be used to pay salaries of some related persons listed in Item 3.
Maxim Group, LLC BrokerCheck CRD 120708 ↗
Leerink Partners LLC BrokerCheck CRD 39011 ↗
Credit Suisse Securities (USA) LLC BrokerCheck CRD 816 ↗		EDGAR ↗
Nov 13, 2014 D
Edge Therapeutics, Inc.
File 021-228305
$595,881$0$0
A portion of the proceeds may be used to pay salaries of some related persons listed in Item 3.
Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Jul 21, 2014 D
Avalo Therapeutics, Inc.
File 021-221427
$0$300,000 (est.)$755,000Trout Capital LLC BrokerCheck CRD 131489 ↗EDGAR ↗
May 22, 2014 D
Diffusion Pharmaceuticals Inc.
File 021-217814
$2,477,850$0$300,000 (est.)
Past due compensation for officers and directors.
Maxim Group LLC BrokerCheck CRD 120708 ↗
via Kareem Ali (CRD 4369152 ↗)
EDGAR ↗
Mar 31, 2014 D/A
MIG IRC, LLC
File 021-183662
$0$0$0None listed on this filingEDGAR ↗
Dec 3, 2013 D/A
Centrexion Therapeutics Corp
File 021-206864
$1,178,311$0$416,388 (est.)
To pay back salary for executive officers: (1) Kerrie L. Brady, (2) James N. Campbell and (3) Jeffrey B. Kindler.
N/A no CRD number reported
via Maxim Group LLC (CRD 120708 ↗)
EDGAR ↗
Dec 3, 2013 D
AMICUS THERAPEUTICS, INC.
File 021-207312
$0$0$0None listed on this filingEDGAR ↗
Dec 3, 2013 D
AMICUS THERAPEUTICS, INC.
File 021-207313
$0$0$0None listed on this filingEDGAR ↗
Dec 3, 2013 D
Centrexion Therapeutics Corp
File 021-207282
$0$0$0 (est.)None listed on this filingEDGAR ↗
Sep 6, 2013 D
Avalo Therapeutics, Inc.
File 021-202469
$555,000 (est.)$0$0 (est.)Maxim Group, LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Mar 25, 2013 D
Edge Therapeutics, Inc.
File 021-193853
$600,608$0$0
A portion of the proceeds may be used to pay salaries of some related persons listed in Item 3.
Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Jan 18, 2013 D
InspireMD, Inc.
File 021-190507
$0$0$0None listed on this filingEDGAR ↗
Nov 2, 2012 D
InspireMD, Inc.
File 021-186426
$0$0$0None listed on this filingEDGAR ↗
Oct 18, 2012 D
InspireMD, Inc.
File 021-185798
$0$0$0None listed on this filingEDGAR ↗
Oct 1, 2012 D
InspireMD, Inc.
File 021-184854
$0$0$0None listed on this filingEDGAR ↗
Oct 1, 2012 D
InspireMD, Inc.
File 021-184855
$0$0$0None listed on this filingEDGAR ↗
Sep 17, 2012 D
Edge Therapeutics, Inc.
File 021-184201
$0$0$0None listed on this filingEDGAR ↗
Jul 30, 2012 D
AMICUS THERAPEUTICS, INC.
File 021-181955
$0$0$0None listed on this filingEDGAR ↗
Apr 18, 2012 D
InspireMD, Inc.
File 021-176894
$848,750$0$0Palladium Capital Advisors, LLC BrokerCheck CRD 129400 ↗
via Palladium Capital Advisors, LLC (CRD 129400 ↗)

OPPENHEIMER & CO. INC. BrokerCheck CRD 249 ↗
via OPPENHEIMER & CO. INC. (CRD 249 ↗)

JMP SECURITIES LLC BrokerCheck CRD 22208 ↗
via JMP SECURITIES LLC (CRD 22208 ↗)
EDGAR ↗
Apr 4, 2012 D
Avalo Therapeutics, Inc.
File 021-176170
$2,207,919 (est.)$0$1,074,960 (est.)Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Sep 15, 2011 D
CONTRAFECT Corp
File 021-165957
$875,203$0$0Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Aug 26, 2011 D
InspireMD, Inc.
File 021-165032
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2011 D
InspireMD, Inc.
File 021-165033
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2011 D
InspireMD, Inc.
File 021-165035
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2011 D
InspireMD, Inc.
File 021-165036
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2011 D
InspireMD, Inc.
File 021-165038
$0$0$0None listed on this filingEDGAR ↗
Nov 5, 2010 D
AMICUS THERAPEUTICS, INC.
File 021-150076
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 9

Every issuer that named Sol J Barer on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CT
Biotechnology

Centrexion Therapeutics Corp

Boston, MA · Nov 22, 2013 → Aug 11, 2022 · 13 filings
  • Aug 11, 2022 · D/A · $29,140,000 sold of $29,140,000 · 47 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 28, 2022 · D/A · $23,750,000 sold of $23,750,000 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 8, 2022 · D · $16,475,000 sold of $16,475,000 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 26, 2021 · D · $13,500,000 sold of $13,500,000 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 2, 2018 · D · $69,566,532 sold of $69,566,532 · 67 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 23, 2017 · D · $5,285,000 sold of Indefinite · 40 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 5, 2017 · D · $16,564,789 sold of $16,564,789 · 14 investors · min. $25,000 · role: Director EDGAR ↗
  • Jun 21, 2016 · D · $11,163,500 sold of Indefinite · 61 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 15, 2016 · D · $6,905,000 sold of Indefinite · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 14, 2016 · D · $10,516,500 sold of Indefinite · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2013 · D/A · $14,728,886 sold of $35,000,000 · 98 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2013 · D · $8,750,000 sold of $8,750,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 22, 2013 · D · $14,728,886 sold of $35,000,000 · 98 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $69.6M from 124 investors (100% of the $29.1M target) as of the latest filing. Sol is listed as director on 13 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AG
Biotechnology

Aevi Genomic Medicine, Inc.

Wayne, PA · Oct 15, 2015 → Oct 19, 2017 · 2 filings
  • Oct 19, 2017 · D · $28,000,000 sold of $28,000,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 15, 2015 · D · $3,200,000 sold of $3,200,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $28M from 88 investors (100% of the $28M target) as of the latest filing. Sol is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Biotechnology

AMICUS THERAPEUTICS, INC.

Princeton, NJ · Nov 5, 2010 → Jul 19, 2016 · 5 filings
  • Jul 19, 2016 · D · $4,706,000 sold of $4,706,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2013 · D · $15,000,000 sold of $15,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2013 · D · $15,000,000 sold of $15,000,000 · 29 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 30, 2012 · D · $18,582,360 sold of $18,582,360 · 1 investors · min. $18,582,360 · role: Director EDGAR ↗
  • Nov 5, 2010 · D · $31,284,583 sold of $31,284,583 · 1 investors · min. $31,284,583 · role: Director EDGAR ↗

Raised $199.9M from 29 investors (100% of the $4.71M target) as of the latest filing. Sol is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

I
Biotechnology

InspireMD, Inc.

Miami, FL · Aug 26, 2011 → Jun 16, 2016 · 13 filings
  • Jun 16, 2016 · D · $182,399 sold of $182,399 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 28, 2016 · D · $609,500 sold of $609,500 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 18, 2013 · D · $3,089,945 sold of $3,089,945 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 2, 2012 · D · $1,763,000 sold of $1,763,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 18, 2012 · D · $450,158 sold of $450,158 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 1, 2012 · D · $408,606 sold of $408,606 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 1, 2012 · D · $0 sold of Indefinite · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 18, 2012 · D · $11,000,000 sold of $11,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2011 · D · $67,000 sold of $67,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2011 · D · $1,500,000 sold of $1,500,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2011 · D · $30,000 sold of $30,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2011 · D · $4,000 sold of $4,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2011 · D · $212,000 sold of $212,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $42.2M from 24 investors (100% of the $182K target) as of the latest filing. Sol is listed as director on 13 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ET
Pharmaceuticals

Edge Therapeutics, Inc.

Berkeley Heights, NJ · Sep 17, 2012 → Apr 9, 2015 · 4 filings
  • Apr 9, 2015 · D · $55,999,978 sold of $56,000,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 13, 2014 · D · $7,937,236 sold of $25,000,000 · 104 investors · min. $10,000 · role: Director EDGAR ↗
  • Mar 25, 2013 · D · $6,673,405 sold of $20,000,000 · 52 investors · min. $50,000 · role: Director EDGAR ↗
  • Sep 17, 2012 · D · $118,500 sold of $3,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $56M from 104 investors (100% of the $56M target) as of the latest filing. Sol is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Biotechnology

Avalo Therapeutics, Inc.

Rockville, MD · Apr 4, 2012 → Jul 21, 2014 · 3 filings
  • Jul 21, 2014 · D · $16,259,016 sold of $33,259,016 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 6, 2013 · D · $6,805,883 sold of $10,000,000 · 146 investors · min. $5,000 · role: Director EDGAR ↗
  • Apr 4, 2012 · D · $22,137,301 sold of $22,500,000 · 156 investors · min. $24,000 · role: Director EDGAR ↗

Raised $130.6M from 156 investors (100% of the $33.3M target) as of the latest filing. Sol is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

DP
Pharmaceuticals · group: Diffusion Pharmaceuticals

Diffusion Pharmaceuticals Inc.

Charlottesville, VA · May 22, 2014
  • May 22, 2014 · D · $24,778,500 sold of $50,000,000 · 146 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $85.7M from 181 investors (100% of the $50M target) as of the latest filing. Sol is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MI
Other Health Care

MIG IRC, LLC

Mendham, NJ · Sep 5, 2012 → Mar 31, 2014 · 2 filings
  • Mar 31, 2014 · D/A · $3,469,656 sold of Indefinite · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 5, 2012 · D · $2,273,000 sold of Indefinite · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3.47M from 22 investors as of the latest filing. Sol is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CC
Biotechnology

CONTRAFECT Corp

Yonkers, NY · Sep 15, 2011
  • Sep 15, 2011 · D · $12,502,905 sold of $25,000,000 · 125 investors · min. $25,000 · role: Director EDGAR ↗

Raised $20M from 125 investors (80% of the $25M target) as of the latest filing. Sol is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Sol Barer — TX, VA, 1 issuer, Apr 4, 2022 → Apr 4, 2022 · no shared issuer

People around Sol 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

IB
No photo found yet (own website and image search run after this page is viewed)
Person

Isaac Blech

Director · 19 shared filings (7 issuers) · also on 13 other issuers

Isaac Blech is on 20 issuers in total — a repeat sponsor. Their page lists every one.

CS
No photo found yet (own website and image search run after this page is viewed)
Person

Craig Shore

Executive Officer · 13 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Asher Holzer

Executive Officer, Director · 11 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

OP
No photo found yet (own website and image search run after this page is viewed)
Person

Ofir Paz

Executive Officer, Director · 11 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

EW
No photo found yet (own website and image search run after this page is viewed)
Person

Eyal Weinstein

Director · 11 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Stuka

Director · 11 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

James N. Campbell

Executive Officer, Director · 10 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

James Loughlin

Director · 10 shared filings (2 issuers)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

AO
No photo found yet (own website and image search run after this page is viewed)
Person

Arnold L. Oronsky

Director · 9 shared filings (1 issuer) · also on 14 other issuers

Arnold L. Oronsky is on 15 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Barry

Director, Executive Officer · 8 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Sol J Barer. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Kerrie L. Brady

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey B. Kindler

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Randall M. Stevens

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey B. Kindler

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

Donald J. Hayden, Jr.

Director · 5 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Eli Bar

Executive Officer · 5 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Sol J Barer. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Margaret G. McGlynn

Director · 5 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Raab

Director · 5 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John F. Crowley

Executive Officer, Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

RR
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Ratini

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

ST
No photo found yet (own website and image search run after this page is viewed)
Person

Shawn Tomasello

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Eugene Bauer

Director · 5 shared filings (2 issuers) · also on 9 other issuers

Eugene Bauer is on 11 issuers in total — a repeat sponsor. Their page lists every one.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gregg Beloff

Executive Officer · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Sol J Barer. Their page shows their other deals.

RE
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Essner

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

CS
No photo found yet (own website and image search run after this page is viewed)
Person

Carl J. Soranno

Executive Officer, Promoter · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

WB
No photo found yet (own website and image search run after this page is viewed)
Person

William D. Baird, III

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

DL
No photo found yet (own website and image search run after this page is viewed)
Person

David Lockhart

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James N. Topper

Director · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

John R. Kirk

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Barrett

Director · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

Glenn Sblendorio

Director · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Bradley L. Campbell

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

KV
No photo found yet (own website and image search run after this page is viewed)
Person

Ken Valenzano

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

Brian A. Leuthner

Executive Officer, Director, Promoter · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

KC
No photo found yet (own website and image search run after this page is viewed)
Person

Kurt Conti

Director · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Ted W. Love

Director · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

DQ
No photo found yet (own website and image search run after this page is viewed)
Person

Daphne Quimi

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

SZ
No photo found yet (own website and image search run after this page is viewed)
Person

Shengda Zan

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph R. Swedish

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Sol J Barer. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

Michael J. Ward

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Sol J Barer. Their page shows their other deals.

The team behind the deals

DP
Sponsor group

Diffusion Pharmaceuticals

2 issuers · 16 filings · $3.15M reported sold · 2009–2020

One team, 2 deal companies. Sol J Barer is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Sol J Barer.

Same business address

18 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 9 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Sol J Barer by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 9 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Sol J Barer is listed on: none on file. No website or social profile named in AMICUS THERAPEUTICS, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #114,459 of 374,652 in line (1,282 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Princeton, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗New York WebCivil Supreme ↗Maryland Judiciary case search ↗California — find the county court ↗Los Angeles Superior Court case search ↗Pennsylvania UJS portal case search ↗Massachusetts MassCourts ↗Virginia state courts — find the court ↗Hillsborough County FL Clerk (HOVER) ↗Miami-Dade Clerk online case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗New York Secretary of State business search ↗Maryland Secretary of State business search ↗California Secretary of State business search ↗Pennsylvania Secretary of State business search ↗Massachusetts Secretary of State business search ↗Virginia Secretary of State business search ↗Florida Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Sol J Barer appears on a new Form D, or when a court case or SEC action is matched to them. See plans →